Case Reports
doi: 10.3343/alm.2018.38.3.277.
NDM-5 and OXA-48 Co-producing Uropathogenic Escherichia coli Isolate: First Case in Korea
Affiliations
- PMID: 29401566
- PMCID: PMC5820076
- DOI: 10.3343/alm.2018.38.3.277
Item in Clipboard
Case Reports
NDM-5 and OXA-48 Co-producing Uropathogenic Escherichia coli Isolate: First Case in Korea
Ann Lab Med.
2018 May.
No abstract available
Conflict of interest statement
No potential conflicts of interest were reported.
Similar articles
-
Translational Efficacy of Humanized Exposures of Cefepime, Ertapenem, and Levofloxacin against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Complicated Urinary Tract Infection.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01329-17. doi: 10.1128/AAC.01329-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28848015 Free PMC article.
-
Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.BMC Infect Dis. 2015 Oct 13;15:414. doi: 10.1186/s12879-015-1153-z. BMC Infect Dis. 2015. PMID: 26464143 Free PMC article.
-
[Current antibiotic resistance profile of uropathogenic Escherichia coli strains and therapeutic consequences].Prog Urol. 2014 Dec;24(16):1058-62. doi: 10.1016/j.purol.2014.09.035. Epub 2014 Oct 11. Prog Urol. 2014. PMID: 25310915 French.
-
CTX-M-32 beta-lactamase-producing uropathogenic Escherichia coli isolated in Latin America.J Infect Dev Ctries. 2013 May 13;7(5):432-5. doi: 10.3855/jidc.3488. J Infect Dev Ctries. 2013. PMID: 23669435 No abstract available.
-
Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.Expert Rev Anti Infect Ther. 2012 Oct;10(10):1165-76. doi: 10.1586/eri.12.110. Expert Rev Anti Infect Ther. 2012. PMID: 23199402 Review.
Cited by
-
Various Sequence Types of Enterobacteriaceae Isolated from Commercial Chicken Farms in China and Carrying the blaNDM-5 Gene.Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00779-18. doi: 10.1128/AAC.00779-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30038045 Free PMC article.
-
Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.Microb Genom. 2018 Jul;4(7):e000197. doi: 10.1099/mgen.0.000197. Epub 2018 Jul 23. Microb Genom. 2018. PMID: 30035710 Free PMC article. Review.
-
Cross-Border Emergence of Escherichia coli Producing the Carbapenemase NDM-5 in Switzerland and Germany.J Clin Microbiol. 2021 Feb 18;59(3):e02238-20. doi: 10.1128/JCM.02238-20. Print 2021 Feb 18. J Clin Microbiol. 2021. PMID: 33361340 Free PMC article.
-
Gram-Negative Bacteria Harboring Multiple Carbapenemase Genes, United States, 2012-2019.Emerg Infect Dis. 2021;27(9):2475-2479. doi: 10.3201/eid2709.210456. Emerg Infect Dis. 2021. PMID: 34424168 Free PMC article.
-
Nosocomial Outbreak Caused by NDM-5 and OXA-181 Carbapenemase Co-producing Escherichia coli.Infect Chemother. 2019 Jun;51(2):177-182. doi: 10.3947/ic.2019.51.2.177. Infect Chemother. 2019. PMID: 31270997 Free PMC article.
References
-
- Ahn S, Sung JY, Kim H, Kim MS, Hwang Y, Jong S, et al. Molecular epidemiology and characterization of carbapenemase-producing Enterobacteriaceae isolated at a university hospital in Korea during 4-year period. Ann Clin Microbiol. 2016;19:39–47.
-
- Dortet L, Poirel L, Al Yaqoubi F, Nordmann P. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect. 2012;18:E144–E148. - PubMed
-
- Yoo JS, Kim HM, Koo HS, Yang JW, Yoo JI, Kim HS, et al. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital. J Antimicrob Chemother. 2013;68:2170–2172. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
